Disruptive Pharma AB
ABActiveOrg 5591746085UppsalaResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2018 · 7 years old5-9 employees
Loading company…
Disruptive Pharma AB is a Swedish AB based in Uppsala, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2018, the company reported revenue of 1,2 mn kr in its latest annual filing.
In its most recent annual report (2024), Disruptive Pharma AB reported revenue of 1,2 mn kr, an increase of 27% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of 29,0 mn kr, and the EBITDA margin stood at -2,513.6%.
At the end of 2024, equity financed 2.3% of the balance sheet, and current assets covered short-term debt 1 times.